IceCure Medical

0.29
开盘价
0.29
市值
24.35M+
最高价
0.31
最低价
0.28
收盘价
0.30
成交量
524.49K+
市盈率
-1.02
股息率
0.00%

IceCure Medical简介

IceCure Medical Ltd.于2006年在以色列注册成立。该公司是一家商业阶段的医疗器械公司,专注于液氮或LN2治疗肿瘤的冷冻消融系统和技术的研究、开发和营销。他们专有的冷冻消融技术是手术干预的微创替代方案,适用于肿瘤,包括在乳房、肺、肾、骨骼和其他适应症中发现的肿瘤。他们在行业领先的商业冷冻消融产品是ProSense系统。公司网站:http://www.icecure-medical.com公司地址:7 HaEshel St. PO Box 3163 Caesarea 3079504 Israel

如何购买 IceCure Medical (ICCM)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 ICCM

购买 ICCM

通过 RockFlow App 或网页端搜索 ICCM,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.